NasdaqGS - Delayed Quote USD

LifeStance Health Group, Inc. (LFST)

5.88
+0.04
+(0.68%)
At close: June 9 at 4:00:01 PM EDT
5.90
+0.02
+(0.32%)
After hours: June 9 at 7:52:16 PM EDT
Loading Chart for LFST
  • Previous Close 5.84
  • Open 5.87
  • Bid 5.84 x 1900
  • Ask 5.91 x 1900
  • Day's Range 5.78 - 6.03
  • 52 Week Range 4.64 - 8.61
  • Volume 1,692,764
  • Avg. Volume 1,868,226
  • Market Cap (intraday) 2.287B
  • Beta (5Y Monthly) 1.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.09
  • Earnings Date Aug 8, 2025 - Aug 13, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.86

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

lifestance.com

7,535

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LFST

View More

Performance Overview: LFST

Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LFST
20.22%
S&P 500 (^GSPC)
2.11%

1-Year Return

LFST
4.07%
S&P 500 (^GSPC)
12.32%

3-Year Return

LFST
17.76%
S&P 500 (^GSPC)
49.48%

5-Year Return

LFST
70.60%
S&P 500 (^GSPC)
87.26%

Compare To: LFST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LFST

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    2.29B

  • Enterprise Value

    2.63B

  • Trailing P/E

    --

  • Forward P/E

    121.95

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.74

  • Price/Book (mrq)

    1.57

  • Enterprise Value/Revenue

    2.05

  • Enterprise Value/EBITDA

    55.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.78%

  • Return on Assets (ttm)

    -0.33%

  • Return on Equity (ttm)

    -2.47%

  • Revenue (ttm)

    1.28B

  • Net Income Avi to Common (ttm)

    -35.64M

  • Diluted EPS (ttm)

    -0.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    135.18M

  • Total Debt/Equity (mrq)

    33.09%

  • Levered Free Cash Flow (ttm)

    113.77M

Research Analysis: LFST

View More

Company Insights: LFST

Research Reports: LFST

View More

People Also Watch